XML 27 R15.htm IDEA: XBRL DOCUMENT v3.26.3
STOCKHOLDERS’ DEFICIT
9 Months Ended
Sep. 30, 2026
Equity [Abstract]  
STOCKHOLDERS’ DEFICIT

NOTE 7. STOCKHOLDERS’ DEFICIT

 

Common Stock

 

As of September 30, 2026, the Company had 15,736,540 shares of common stock issued and outstanding. For accounting purposes related to earnings per share, only shares that are fully vested are considered issued and outstanding.

 

Below is a reconciliation of shares of common stock issued and outstanding:

 

   September 30, 2026 
Total shares of common stock issued and outstanding   15,736,540 
Plus: shares to be issued:     
Vested RSUs not yet legally settled into common stock (a)   54,335 
Pre-funded warrants not yet legally settled into common stock (b)   375,000 
Less: Shares subject to future vesting:     
Issuance of restricted common stock subject to forfeiture (c)   (11,941,979)
Total shares, net   4,223,896 

 

(a) As of September 30, 2026, there were RSUs that had vested but had not been legally settled into common stock.
   
(b) As of September 30, 2026, the pre-funded warrants had not been legally settled into common stock.
   
(c) The Company’s executive officers will automatically forfeit all unvested Restricted Stock in the event they depart the Company.

 

Pre-funded Warrants

 

On May 15, 2026, the Company closed the sale of the Pre-funded Warrants to purchase up to 375,000 shares of common stock to a single accredited investor, the Patel Family, in a private placement exempt from registration under Section 4(a)(2) of the Securities Act pursuant to a Securities Purchase Agreement dated May 11, 2026. The Pre-funded Warrants were sold for an aggregate purchase price of $3,000,000, representing an issue price of $0.0001 per warrant plus prepayment of substantially all of the per-share exercise price. Each Pre-funded Warrant is exercisable for one share of the Company’s common stock, par value $0.0001 per share, at a remaining exercise price of $0.0001 per share, and does not expire until exercised in full.

 

The Pre-funded Warrants may be exercised for cash or, at the holder’s election, on a cashless basis. The Company is not required, under any circumstance, to settle the Pre-funded Warrants in cash. The holder’s ability to exercise the Pre-funded Warrants is limited to a beneficial ownership cap of 9.99% of the Company’s then-outstanding common stock, which the holder may increase to up to 19.99% upon 61 days’ prior written notice to the Company.

 

As of September 30, 2026, none of the Pre-funded Warrants had been exercised. As of September 30, 2026, there are 375,000 Pre-funded Warrants outstanding.

 

Public Warrants

 

As of September 30, 2026, there are 347,732 public warrants outstanding.

 

Private Placement Warrants

 

As of September 30, 2026, there are 11,768 private placement warrants outstanding.

 

See Note 3 for additional information on the Company’s warrant accounting policy.

 

Series C Preferred Stock

 

Under the terms of the Series C Preferred Stock, dividends are payable quarterly through the issuance of additional shares of Series C Preferred Stock (“PIK Shares”) or, at the Company’s election, in cash. During the nine months ended September 30, 2026, the Company’s Board of Directors declared and settled quarterly dividends through the issuance of 78.2 PIK Shares with an aggregate fair value of $782,000. These issuances were accounted for as non-cash transactions, resulting in a reduction to Retained Earnings and a corresponding increase to Preferred Stock.